Tumor-targeted inhibition of TAP also inhibited the growth of tamoxifen-induced tumors in the BRAF/PTEN melanoma model when used in combination with PD-1 Ab and Flt3 ligand (Fig. 3f). The gene discussed is PDCD1; the disease is melanoma.